We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-8.50 | -0.48% | 1,775.00 | 1,771.00 | 1,771.50 | 1,779.00 | 1,764.50 | 1,773.50 | 9,685,415 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.80 | 72.91B |
Date | Subject | Author | Discuss |
---|---|---|---|
09/6/2015 10:43 | You have to allow for the UKX level as well, we have come off over 200 now. GSK is off more than double that on a % basis. | essentialinvestor | |
09/6/2015 10:32 | Reinvest the div and wait. Only strategy. | blueledge2 | |
09/6/2015 10:07 | Witty will not go down without a fight, 30 years with GSK, it would be a humiliating way to end his career imv as this is his strategy. I would expect every single measure to extract value being considered over the next 12 months, with deeper cost costs than previous guidance as one option. | essentialinvestor | |
09/6/2015 10:00 | Ultimate breakup more likely Michael if growth is not re-established. New CEO, strategic review .. ? How much would the OTC business be worth to RB. alone, as one example, GSK have an option to buy Novartis out of their minority stake. | essentialinvestor | |
09/6/2015 09:58 | Never mind - a bid coming at this rate ...... ;0) | tradermichael | |
09/6/2015 09:57 | Depends on your timeframe blue, but you are getting a fat income stream (at least for now) while you wait. | essentialinvestor | |
09/6/2015 09:54 | I am just frustrated having brought at the wrong time. | blueledge2 | |
09/6/2015 09:50 | Well if this rate of decline continued by November GSK would be worthless, so no it is very unlikely to go down every day ). | essentialinvestor | |
09/6/2015 09:32 | Down again. Predictable. Cant go down every day? | blueledge2 | |
09/6/2015 08:53 | Video interview with the CEO on the FT site, agree with a lot of what Witty says, he makes some valid points, worth a watch. He has about 12 months to restart growth IMV. | essentialinvestor | |
08/6/2015 15:54 | I've just read. | essentialinvestor | |
08/6/2015 15:47 | Now they have a problem with noodles. You could not make it up| | blueledge2 | |
08/6/2015 15:30 | Seems to be down every day. | blueledge2 | |
08/6/2015 13:11 | Few would disagree, just about where you see the valuation. Now in correction territory here, more than 10% from the high. | essentialinvestor | |
08/6/2015 11:25 | Still think this is a great company. I'm adding into weakness :0). This seems minor DYOR, DONT FOLLOW ME :0) | solooiler | |
08/6/2015 10:38 | Mine is a metered does, it counts down on each use. Easy to carry around as it's much smaller than my blue inhaler. | essentialinvestor | |
08/6/2015 10:36 | It is important to note, though Advair/Seretide had gone off US patent in end 2010, the patent protection for the “Diskus” device that dispenses the powder version of the fixed dose drugs combination, continues till 2016. For the inhaler device that dispenses the aerosol version of the same drugs, the patent remains valid until 2025. | tradermichael | |
08/6/2015 10:23 | Me too,does that mean that the health service will stop using Glaxo's,or do they reduce the price? Brilliant stuff I find. | 2hoggy | |
08/6/2015 09:32 | Seretide generic launch in the UK announced, might be the generic version on my next prescription as I use it. | essentialinvestor | |
08/6/2015 09:23 | Only one month for the divi payout. 19p/share will enable me to buy loads more ..... 0) | tradermichael | |
08/6/2015 08:42 | The sun will come out tomorrow eh Michael?. Its Always a day away with GSK. | essentialinvestor | |
08/6/2015 08:03 | Not another down day surely? | blueledge2 | |
07/6/2015 17:59 | Plenty new potential here: | tradermichael | |
06/6/2015 12:07 | Spread Betting and CFDs June Magazine edition now online at This month's premium features includes: How to Pick the Perfect Share - the Seven Secrets to Success - Searching for Quality Companies - Robbie Burns' Trading Diary - Mellon on the Markets - Currency Corner - Fund Manager: Emmanuel Lemelson - Why I'm a Long-Term US Dollar Bull and much more... | shar65 | |
06/6/2015 11:57 | hxxp://www.barchart. check this out might be further to fall | mj19 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions